wikipedia - 28 Mar 2018 Hyperparathyroidism is an increased parathyroid hormone (PTH) levels in the blood. This occurs either from the parathyroid glands inappropriately making too much PTH (primary hyperparathyroidism) or other events triggering increased production by the parathyroid glands (secondary hyperparathyroidism). Most people with primary disease have no symptoms at the time of diagnosis. In those with symptoms the most common is kidney stones with other potential symptoms including weakness, depression, bone pai
Rochester Leader - 17 Feb 2019
Secondary Hyperparathyroidism Pipeline insight report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and ...
Thе Prеss Rеvіеwеr - 15 Feb 2019
Secondary Hyperparathyroidism Market Report 2019 provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery ...
MD Linx - 22 Jan 2019
Internal Medicine Article: Primary hyperparathyroidism in pregnancy: Maternofetal outcomes at a quaternary referral obstetric hospital, 2000 through 2015.
Nevada Green Times - 07 Feb 2019
Latest Industry Research Report On “Secondary Hyperparathyroidism – Epidemiology Forecast To 2028” in-depth analysis of the market state and also the ...
TOP Tribune - 10 Feb 2019
Secondary Hyperparathyroidism Treatment Market 2019 Research Report including industry overview in terms of historic and present situation key ...
Oak Tribune - 06 Feb 2019
The Secondary Hyperparathyroidism Treatment Market is expected to have a highly positive outlook for the next five years 2018-2026 according to a recently ...
Nevada Green Times - 15 Feb 2019
“Hyperparathyroidism – Epidemiology Forecast, 2028 report provides a comprehensive analysis of the Hyperparathyroidism epidemiology, providing the ...
reportsherald.com - 23 Jan 2019
The Global Secondary Hyperparathyroidism Treatment Market Research Report Forecast 2019-2025 is a valuable source of insightful data for business ...
Renal and Urology News - 12 Feb 2019
Using cinacalcet in combination with other therapies may be even more efficacious than monotherapy for calciphylaxes, a review suggests.
Renal and Urology News - 11 Feb 2019
Findings suggest that patients on peritoneal dialysis who have hungry bone syndrome respond better to treatment than those on hemodialysis.
Global News Tribune - 27 Jan 2019
Report Titled “Secondary Hyperparathyroidism – Pipeline Insight, 2018” provides product and API manufacturers' details across the globe along with the ...
Renal and Urology News - 24 Jan 2019
In the not-so-distant future, calcimimetic drugs will be added to the Medicare ESRD Prospective Payment System (PPS) bundle. Findings from a new study, ...
Hollywood Reporter - 04 Feb 2019
UCLA's David Geffen School of Medicine on Monday revealed that it had received a $15.2 million bequest from the estate of comedian Garry Shandling, who ...
Dove Medical Press - 31 Jul 2018
Management and outcomes of hyperparathyroidism: a case series from a single institution over two decades Hassan Al-Thani,1 Moamena El-Matbouly,1 ...
MENAFN.COM - 13 Feb 2019
(MENAFN - GetNews) Parathyroid Disorders Market report gives expected growth of Top players at CAGR 6.5% during the forecast period of 2018–2023. Glob.
Renal and Urology News - 29 Jan 2019
New findings from a real-world study confirm that active vitamin D improves survival in hemodialysis (HD) patients. Of 52,757 HD patients in Taiwan's National ...
Renal and Urology News - 01 Feb 2019
Researchers may have a new target with which to study cardiovascular risks in patients on hemodialysis (HD) who suffer from secondary hyperparathyroidism ...
